| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5877476 | The American Journal of Medicine | 2016 | 31 Pages |
Abstract
Choice of antithrombotic therapy in patients with atrial fibrillation and coronary artery disease was not affected by patient stroke or bleeding risks. Triple antithrombotic therapy-treated patients were more likely to be hospitalized for all causes than those on OAC plus AA or on DAP.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Renato D. MD, MHS, PhD, Meena MD, DaJuanicia N. MS, Laine PhD, Jack MD, Gregg C. MD, Bernard J. MB, ChB, DPhil, Alan S. MD, Elaine M. MD, MPH, Peter MD, Jonathan P. MD, MHS, Daniel E. MD, Paul MD, Eric D. MD, MPH, Kenneth W. MD,